Prof. Riccardo Dolcetti
Head, Translational And Clinical Immunotherapy
Microbiology and Immunology
361 Scholarly works
2 Projects
HIGHLIGHTS
2021
Journal article
Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression
DOI: 10.3390/cancers131537332021
Journal article
Understanding the immuno-biology of oesophageal adenocarcinoma: Towards improved therapeutic approaches
DOI: 10.1016/j.ctrv.2021.1022192021
Conference Proceedings
Abstract 272: Glycomics: Protein glycosylation changes in the pathogenesis of head and neck cancer
DOI: 10.1158/1538-7445.am2021-2722021
Conference Proceedings
Abstract 1443: CHKing melanoma: CHK1 inhibitor low dose hydroxyurea triggers immunogenic cell death and immunostimulatory cytokine expression to drive an anti-tumor immune response
DOI: 10.1158/1538-7445.am2021-14432021
Journal article
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing
DOI: 10.1016/j.omtm.2021.04.0092021
Research Grant
Exploitation of the immunogenicity of CEP55 to enhance the efficacy of immunotherapy for triple-negative breast cancer
2021
Research Grant
Reprogramming anti-tumour therapy responses by locus selective manipulation of the epigenome in breast cancer
RECENT SCHOLARLY WORKS
2021
Journal article
Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases
DOI: 10.3390/biology100504252021
Journal article
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases
DOI: 10.1111/liv.146672020
Journal article
Protein glycosylation in head and neck cancers: From diagnosis to treatment
DOI: 10.1016/j.bbcan.2020.1884222020
Journal article
Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?
DOI: 10.3390/cancers121133922020
Journal article
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation
DOI: 10.1038/s41417-020-00246-9